Table 1.

% prevalence of IFDMs detected in sera samples infected with HCV genotypes 3a, 2a, 1b (A) and liver tissue infected with HCV genotypes 1b, 2a (B).

HCV genotype	(n)	WT (n)	NONA (n)	IFDMs (n)	% IFDMs
A
1b	23	8	9	6	26
2a	35	9	19	7	20
3a/c	31	9	14	8	25,8
B
2a	12 (4∗)		7	1	8,3
1b	45	32	4	9	20

NONA, non-amplified; (n), number of samples. ^∗mispriming (checked by sequence).